NCT00498433View on ClinicalTrials.gov

Effects of Aliskiren and Amlodipine on the Renin-Angiotensin System (RAS) and Lipid/Carbohydrate Metabolism in Obese Patients With Hypertension

PHASE2TerminatedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
HypertensionAbdominal Obesity
Interventions
DRUG

Aliskiren

300 mg tablet once daily

DRUG

Amlodipine

5 mg capsule once daily

DRUG

Placebo of Aliskiren

Matching placebo of aliskiren 300 mg tablet

DRUG

Placebo of amlodipine

Matching placebo of amlodipine 5 mg capsule

Trial Locations (2)

13125

Novartis Investigative Site, Buch

30159

Novartis Investigative Site, Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY